Randomized and multicenter clinical trial to evaluate the safety and tolerability of clozapine against routine clinical practice treatment in treatment-resistant psychosis in adolescents and adults j
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN FOUNDATION FOR THE MANAGEMENT OF HEALTH RESEARCH IN SEVILLE
- Phase: II
- Execution start: 30/09/2020
- End of execution: 30/10/2023
- IP: JORGE ANTONIO CERVILLA BALLESTEROS